​

DaVita (DVA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

DVA Stock Forecast

DaVita (DVA) stock forecast, based on 23 Wall Street analysts, predicts a 12-month average price target of $168.67, with a high of $190.00 and a low of $158.00. This represents a 10.20% increase from the last price of $153.06.

$100 $118 $136 $154 $172 $190 High: $190 Avg: $168.67 Low: $158 Last Closed Price: $153.06

DVA Stock Rating

DaVita stock's rating consensus is Hold, based on 23 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (34.78%), 14 Hold (60.87%), 1 Sell (4.35%), and 0 Strong Sell (0.00%).

Hold
Total 23 1 14 8 0 Strong Sell Sell Hold Buy Strong Buy

DVA Price Target Upside V Benchmarks

TypeNameUpside
StockDaVita10.20%
SectorHealthcare Stocks 15.45%
IndustryMedical Care Facilities Stocks21.19%

Price Target Trends

1M3M12M
# Anlaysts-37
Avg Price Target-$168.67$155.14
Last Closing Price$153.06$153.06$153.06
Upside/Downside-10.20%1.36%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 26-16-18
Feb, 26117-110
Jan, 26-17-19
Dec, 25-17-19
Nov, 25-17-19
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 05, 2026Truist Financial$158.00$144.429.40%3.23%
Feb 04, 2026UBS$190.00$134.7341.02%24.13%
Feb 03, 2026Barclays$158.00$111.1942.10%3.23%
Oct 30, 2025Barclays$143.00$126.5612.99%-6.57%
Oct 14, 2025David MacDonaldTruist Financial$140.00$123.3613.49%-8.53%
Oct 09, 2025Andrew MokBarclays$149.00$127.8916.51%-2.65%
Aug 08, 2025David MacDonaldTruist Financial$148.00$129.5414.25%-3.31%
Feb 21, 2025Lisa Bedell CliveBernstein$184.00$142.4029.21%20.21%
Aug 07, 2024Kevin FischbeckBank of America Securities$145.00$133.538.59%-5.27%
May 06, 2024Andrew MokBarclays$150.00$134.4511.57%-2.00%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 04, 2026UBSBuyBuyhold
Feb 03, 2026Cowen & Co.HoldHoldhold
Dec 15, 2025UBSBuyBuyhold
Nov 03, 2025Cowen & Co.HoldHoldhold
May 19, 2025Cowen & Co.HoldHoldhold
Feb 18, 2025Cowen & Co.HoldHoldhold
May 06, 2024BarclaysEqual-WeightEqual-Weighthold
Jan 05, 2023CFRAHoldupgrade
Aug 19, 2022UBSBuyupgrade
Jun 28, 2022BarclaysEqual-WeightEqual-Weighthold

Financial Forecast

EPS Forecast

$5 $8 $11 $14 $17 $20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$9.30$5.88$7.62$11.02$10.06---
Avg Forecast$8.89$6.21$7.98$9.69$11.41$13.71$15.04$16.96
High Forecast$9.04$6.25$8.10$9.76$12.05$15.54$16.82$17.41
Low Forecast$8.76$6.15$7.77$9.64$10.75$11.99$13.26$16.81
Surprise %4.61%-5.31%-4.51%13.73%-11.83%---

Revenue Forecast

$11B $12B $13B $14B $15B $16B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$11.62B$11.61B$12.14B$12.82B$13.64B---
Avg Forecast$11.59B$11.62B$12.01B$12.78B$13.33B$13.79B$14.53B$15.02B
High Forecast$11.74B$11.69B$12.04B$12.83B$13.37B$13.81B$14.61B$15.33B
Low Forecast$11.46B$11.55B$11.98B$12.74B$13.29B$13.78B$14.44B$14.92B
Surprise %0.28%-0.12%1.11%0.25%2.39%---

Net Income Forecast

$500M $800M $1B $1B $2B $2B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$978.45M$560.40M$691.53M$936.34M$746.80M---
Avg Forecast$838.97M$839.66M$691.53M$903.84M$1.06B$1.28B$1.40B$1.58B
High Forecast$1.01B$1.01B$829.84M$909.42M$1.12B$1.45B$1.57B$1.62B
Low Forecast$671.18M$671.73M$553.23M$898.26M$1.00B$1.12B$1.24B$1.57B
Surprise %16.63%-33.26%-3.60%-29.70%---

DVA Forecast FAQ

Is DaVita stock a buy?

DaVita stock has a consensus rating of Hold, based on 23 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 14 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that DaVita is a neutral investment for most analysts.

What is DaVita's price target?

DaVita's price target, set by 23 Wall Street analysts, averages $168.67 over the next 12 months. The price target range spans from $158 at the low end to $190 at the high end, suggesting a potential 10.20% change from the previous closing price of $153.06.

How does DaVita stock forecast compare to its benchmarks?

DaVita's stock forecast shows a 10.20% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical care facilities stocks industry (21.19%).

What is the breakdown of analyst ratings for DaVita over the past three months?

  • March 2026: 0% Strong Buy, 12.50% Buy, 75.00% Hold, 0% Sell, 12.50% Strong Sell.
  • February 2026: 10.00% Strong Buy, 10.00% Buy, 70.00% Hold, 0% Sell, 10.00% Strong Sell.
  • January 2026: 0% Strong Buy, 11.11% Buy, 77.78% Hold, 0% Sell, 11.11% Strong Sell.

What is DaVita’s EPS forecast?

DaVita's average annual EPS forecast for its fiscal year ending in December 2026 is $13.71, marking a 36.28% increase from the reported $10.06 in 2025. Estimates for the following years are $15.04 in 2027, and $16.96 in 2028.

What is DaVita’s revenue forecast?

DaVita's average annual revenue forecast for its fiscal year ending in December 2026 is $13.79B, reflecting a 1.11% increase from the reported $13.64B in 2025. The forecast for 2027 is $14.52B, and $15.02B for 2028.

What is DaVita’s net income forecast?

DaVita's net income forecast for the fiscal year ending in December 2026 stands at $1.28B, representing an 71.78% increase from the reported $746.8M in 2025. Projections indicate $1.4B in 2027, and $1.58B in 2028.